McKesson Corporation stock is down -0.56% since 30 days ago. The next earnings date is Jan 31, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 53.33% of the previous 29 December’s closed higher than November. In the last 10 Unusual Options Trades, there were 5 PUTs, 5 CALLs. 100% of analysts rate it a buy.
Date & Time | Expiration Date | Strike Price | Trade Type | Size | Open Interest |
---|---|---|---|---|---|
30 Nov 17:44 | 19 Jan, 2024 | 470.00 | 48 | ||
30 Nov 18:22 | 01 Dec, 2023 | 230.00 | 0 | ||
30 Nov 18:37 | 01 Dec, 2023 | 230.00 | 0 | ||
01 Dec 16:48 | 17 Jan, 2025 | 460.00 | 75 | ||
01 Dec 16:48 | 17 Jan, 2025 | 460.00 | 75 | ||
04 Dec 17:23 | 16 Jan, 2026 | 210.00 | 1 | ||
04 Dec 20:17 | 17 Jan, 2025 | 460.00 | 80 | ||
06 Dec 15:18 | 19 Jan, 2024 | 480.00 | 1151 | ||
06 Dec 15:48 | 19 Jan, 2024 | 470.00 | 303 | ||
07 Dec 19:10 | 19 Jan, 2024 | 470.00 | 293 |
McKesson Corporation provides healthcare supply chain management, retail pharmacy, community oncology and specialty care, and healthcare information solutions. It operates through four segments: U.S. Pharmaceutical, International, Medical-Surgical Solutions, and Prescription Technology Solutions. The RxTS segment offers CoverMyMeds solution to help patients get the medications.